AYVAKYT 50mg film-coated tablets BLUEPRINT MEDICINES
Active substance: avapritinib
Indicated for: gastrointestinal stromal tumors; systemic mastocytosis
Find medicines for human use by name or active substance.
Browse by initial
2,101–2,120 of 2,168 medicines
Active substance: avapritinib
Indicated for: gastrointestinal stromal tumors; systemic mastocytosis
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Active substance: aztreonam
J01DF01 Antiinfectives for systemic use | Other beta-lactam antibacterials | Monobactams
Indicated for: bacterial infections
Active substance: aztreonam
J01DF01 Antiinfectives for systemic use | Other beta-lactam antibacterials | Monobactams
Indicated for: bacterial infections
Active substance: desogestrel
Indicated for: contraception
Active substance: cinnarizine + dimenhydrinate
N07CA52 Nervous system | Antivertigo preparations
Indicated for: vertigo; vestibular disorders
Active substance: brinzolamide + timolol
S01ED51 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
Indicated for: glaucoma; ocular hypertension
Active substance: pantoprazole
Indicated for: peptic ulcer; gastroesophageal reflux
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.